[1]
|
Rosenberg, S.A. (1999) A New Era for Cancer Immunotherapy Based on the Genes That Encode Cancer Antigens. Immunity, 10, 281-287. https://doi.org/10.1016/S1074-7613(00)80028-X
|
[2]
|
Coley, W.B. (1891) II. Contribution to the Knowledge of Sarcoma. Annals of Surgery, 14, 199-220. https://doi.org/10.1097/00000658-189112000-00015
|
[3]
|
Couzin-Frankel, J. (2013) Breakthrough of the Year 2013. Cancer Immunotherapy. Science, 342, 1432-1433. https://doi.org/10.1126/science.342.6165.1432
|
[4]
|
Steinman, R.M. and Cohn, Z.A. (1973) Identification of a Novel Cell Type in Peripheral Lymphoid Organs of Mice. I. Morphology, Quantitation, Tissue Distribution. Journal of Experimental Medicine, 137, 1142-1162. https://doi.org/10.1084/jem.137.5.1142
|
[5]
|
Collin, M., McGovern, N. and Haniffa, M. (2013) Human Dendritic Cell Subsets. Immunology, 140, 22-30. https://doi.org/10.1111/imm.12117
|
[6]
|
Banchereau, J. and Steinman, R.M. (1998) Dendritic Cells and the Control of Immunity. Nature, 392, 245-252. https://doi.org/10.1038/32588
|
[7]
|
Steinman, R.M. and Banchereau, J. (2007) Taking Dendritic Cells into Medicine. Nature, 449, 419-426. https://doi.org/10.1038/nature06175
|
[8]
|
Steinman, R.M. (2012) Decisions about Dendritic Cells: Past, Present, and Future. Annual Review of Immunology, 30, 1-22. https://doi.org/10.1146/annurev-immunol-100311-102839
|
[9]
|
Jego, G., Pascual, V., Palucka, A.K. and Banchereau, J. (2005) Dendritic Cells Control B Cell Growth and Differentiation. Current Directions in Autoimmunity, 8, 124-139. https://doi.org/10.1159/000082101
|
[10]
|
Qi, H., Egen, J.G., Huang, A.Y. and Germain, R.N. (2006) Extrafollicular Activation of Lymph Node B Cells by Antigen-Bearing Dendritic Cells. Science, 312, 1672-1676. https://doi.org/10.1126/science.1125703
|
[11]
|
Batista, F.D. and Harwood, N.E. (2009) The Who, How and Where of Antigen Presentation to B Cells. Nature Reviews Immunology, 9, 15-27. https://doi.org/10.1038/nri2454
|
[12]
|
Bergtold, A., Desai, D.D., Gavhane, A. and Clynes, R. (2005) Cell Surface Recycling of Internalized Antigen Permits Dendritic Cell Priming of B Cells. Immunity, 23, 503-514. https://doi.org/10.1016/j.immuni.2005.09.013
|
[13]
|
Palucka, K. and Banchereau, J. (2012) Cancer Immunotherapy via Dendritic Cells. Nature Reviews Cancer, 12, 265-277. https://doi.org/10.1038/nrc3258
|
[14]
|
Wilson, N.S., El-Sukkari, D., Belz, G.T., Smith, C.M., Steptoe, R.J., et al. (2003) Most Lymphoid Organ Dendritic Cell Types Are Phenotypically and Functionally Immature. Blood, 102, 2187-2194. https://doi.org/10.1182/blood-2003-02-0513
|
[15]
|
Trombetta, E.S. and Mellman, I. (2005) Cell Biology of Antigen Processing in Vitro and in Vivo. Annual Review of Immunology, 23, 975-1028. https://doi.org/10.1146/annurev.immunol.22.012703.104538
|
[16]
|
Heath, W.R. and Carbone, F.R. (2001) Cross-Presentation, Dendritic Cells, Tolerance and Immunity. Annual Review of Immunology, 19, 47-64. https://doi.org/10.1146/annurev.immunol.19.1.47
|
[17]
|
Liu, Y.J., Soumelis, V., Watanabe, N., Ito, T., Wang, Y.H., et al. (2007) TSLP: An Epithelial Cell Cytokine That Regulates T Cell Differentiation by Conditioning Dendritic Cell Maturation. Annual Review of Immunology, 25, 193-219. https://doi.org/10.1146/annurev.immunol.25.022106.141718
|
[18]
|
Melero, I., Gaudernack, G., Gerritsen, W., Huber, C., Parmiani, G., et al. (2014) Therapeutic Vaccines for Cancer: An Overview of Clinical Trials. Nature Reviews Clinical Oncology, 11, 509-524. https://doi.org/10.1038/nrclinonc.2014.111
|
[19]
|
Kantoff, P.W., Higano, C.S., Shore, N.D., Berger, E.R., Small, E.J., et al. (2010) Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer. The New England Journal of Medicine, 363, 411-422. https://doi.org/10.1056/NEJMoa1001294
|
[20]
|
Anguille, S., Smits, E.L., Bryant, C., Van Acker, H.H., Goossens, H., et al. (2015) Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy. Pharmacological Reviews, 67, 731-753. https://doi.org/10.1124/pr.114.009456
|
[21]
|
Anguille, S., Smits, E.L., Lion, E., van Tendeloo, V.F. and Berneman, Z.N. (2014) Clinical Use of Dendritic Cells for Cancer Therapy. The Lancet Oncology, 15, e257-e267. https://doi.org/10.1016/S1470-2045(13)70585-0
|
[22]
|
Chiang, C.L., Balint, K., Coukos, G. and Kandalaft, L.E. (2015) Potential Approaches for More Successful Dendritic Cell-Based Immunotherapy. Expert Opinion on Biological Therapy, 15, 569-582. https://doi.org/10.1517/14712598.2015.1000298
|
[23]
|
Mohamadzadeh, M., Berard, F., Essert, G., Chalouni, C., Pulendran, B., et al. (2001) Interleukin 15 Skews Monocyte Differentiation into Dendritic Cells with Features of Langer-hans Cells. Journal of Experimental Medicine, 194, 1013-1020. https://doi.org/10.1084/jem.194.7.1013
|
[24]
|
Dubsky, P., Saito, H., Leogier, M., Dantin, C., Connolly, J.E., et al. (2007) IL-15-Induced Human DC Efficiently Prime Melanoma-Specific Naive CD8+ T Cells to Differentiate into CTL. European Journal of Immunology, 37, 1678-1690. https://doi.org/10.1002/eji.200636329
|
[25]
|
Jongbloed, S.L., Kassianos, A.J., McDonald, K.J., Clark, G.J., Ju, X., et al. (2010) Human CD141+ (BDCA-3)+ Dendritic Cells (DCs) Represent a Unique Myeloid DC Subset That Cross-Presents Necrotic Cell Antigens. Journal of Experimental Medicine, 207, 1247-1260. https://doi.org/10.1084/jem.20092140
|
[26]
|
Ueno, H., Klechevsky, E., Schmitt, N., Ni, L., Flamar, A.L., et al. (2011) Targeting Human Dendritic Cell Subsets for Improved Vaccines. Seminars in Immunology, 23, 21-27. https://doi.org/10.1016/j.smim.2011.01.004
|
[27]
|
Schreibelt, G., Klinkenberg, L.J., Cruz, L.J., Tacken, P.J., Tel, J., et al. (2012) The C-Type Lectin Receptor CLEC9A Mediates Antigen Uptake and (Cross-)presentation by Human Blood BDCA3+ Myeloid Dendritic Cells. Blood, 119, 2284-2292. https://doi.org/10.1182/blood-2011-08-373944
|
[28]
|
Piccioli, D., Tavarini, S., Borgogni, E., Steri, V., Nuti, S., et al. (2007) Functional Specialization of Human Circulating CD16 and CD1c Myeloid Dendritic-Cell Subsets. Blood, 109, 5371-5379. https://doi.org/10.1182/blood-2006-08-038422
|
[29]
|
Alculumbre, S. and Pattarini, L. (2016) Purification of Human Dendritic Cell Subsets from Peripheral Blood. Methods in Molecular Biology, 1423, 153-167. https://doi.org/10.1007/978-1-4939-3606-9_11
|
[30]
|
Lindstedt, M., Lundberg, K. and Borrebaeck, C.A. (2005) Gene Family Clustering Identifies Functionally Associated Subsets of Human in Vivo Blood and Tonsillar Dendritic Cells. The Journal of Immunology, 175, 4839-4846. https://doi.org/10.4049/jimmunol.175.8.4839
|
[31]
|
Edwards, A.D., Diebold, S.S., Slack, E.M., Tomizawa, H., Hemmi, H., et al. (2003) Toll-Like Receptor Expression in Murine DC Subsets: Lack of TLR7 Expression by CD8 Alpha+ DC Correlates with Unresponsiveness to Imidazoquinolines. European Journal of Immunology, 33, 827-833. https://doi.org/10.1002/eji.200323797
|
[32]
|
Galibert, L., Diemer, G.S., Liu, Z., Johnson, R.S., Smith, J.L., et al. (2005) Nectin-Like Protein 2 Defines a Subset of T-Cell Zone Dendritic Cells and Is a Ligand for Class-I-Restricted T-Cell-Associated Molecule. The Journal of Biological Chemistry, 280, 21955-21964. https://doi.org/10.1074/jbc.M502095200
|
[33]
|
Huysamen, C., Willment, J.A., Dennehy, K.M. and Brown, G.D. (2008) CLEC9A Is a Novel Activation C-Type Lectin-Like Receptor Expressed on BDCA3+ Dendritic Cells and a Subset of Monocytes. The Journal of Biological Chemistry, 283, 16693-16701. https://doi.org/10.1074/jbc.M709923200
|
[34]
|
Sancho, D., Mourao-Sa, D., Joffre, O.P., Schulz, O., Rogers, N.C., et al. (2008) Tumor Therapy in Mice via Antigen Targeting to a Novel, DC-Restricted C-Type Lectin. Journal of Clinical Investigation, 118, 2098-2110. https://doi.org/10.1172/JCI34584
|
[35]
|
Poulin, L.F., Salio, M., Griessinger, E., Anjos-Afonso, F., Craciun, L., et al. (2010) Characterization of Human DNGR-1+ BDCA3+ Leukocytes as Putative Equivalents of Mouse CD8alpha+ Dendritic Cells. Journal of Experimental Medicine, 207, 1261-1271. https://doi.org/10.1084/jem.20092618
|
[36]
|
Hochrein, H., Shortman, K., Vremec, D., Scott, B., Hertzog, P., et al. (2001) Differential Production of IL-12, IFN-Alpha, and IFN-Gamma by Mouse Dendritic Cell Subsets. The Journal of Immunology, 166, 5448-5455. https://doi.org/10.4049/jimmunol.166.9.5448
|
[37]
|
Jarrossay, D., Napolitani, G., Colonna, M., Sallusto, F. and Lanzavecchia, A. (2001) Specialization and Complementarity in Microbial Molecule Recognition by Human Myeloid and Plasmacytoid Dendritic Cells. European Journal of Immunology, 31, 3388-3393. https://doi.org/10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q
|
[38]
|
Segura, E., Touzot, M., Bohineust, A., Cappuccio, A., Chiocchia, G., et al. (2013) Human Inflammatory Dendritic Cells Induce Th17 Cell Differentiation. Immunity, 38, 336-348. https://doi.org/10.1016/j.immuni.2012.10.018
|
[39]
|
Siegal, F.P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P.A., Shah, K., et al. (1999) The Nature of the Principal Type 1 Inter-feron-Producing Cells in Human Blood. Science, 284, 1835-1837. https://doi.org/10.1126/science.284.5421.1835
|
[40]
|
Cao, W., Rosen, D.B., Ito, T., Bover, L., Bao, M., et al. (2006) Plasmacytoid Dendritic Cell-Specific Receptor ILT7-Fc epsilonRI Gamma Inhibits Toll-Like Receptor-Induced Interferon Production. Journal of Experimental Medicine, 203, 1399-1405. https://doi.org/10.1084/jem.20052454
|
[41]
|
Di Pucchio, T., Chatterjee, B., Smed-Sorensen, A., Clayton, S., Palazzo, A., et al. (2008) Direct Proteasome-Independent Cross-Presentation of Viral Antigen by Plasmacytoid Dendritic Cells on Major Histocompatibility Complex Class I. Nature Immunology, 9, 551-557. https://doi.org/10.1038/ni.1602
|
[42]
|
Fonteneau, J.F., Gilliet, M., Larsson, M., Dasilva, I., Munz, C., et al. (2003) Activation of Influenza Virus-Specific CD4+ and CD8+ T Cells: A New Role for Plasmacytoid Dendritic Cells in Adaptive Immunity. Blood, 101, 3520-3526. https://doi.org/10.1182/blood-2002-10-3063
|
[43]
|
Tel, J., Schreibelt, G., Sittig, S.P., Mathan, T.S., Buschow, S.I., et al. (2013) Human Plasmacytoid Dendritic Cells Efficiently Cross-Present Exogenous Ags to CD8+ T Cells Despite Lower Ag Uptake than Myeloid Dendritic Cell Subsets. Blood, 121, 459-467. https://doi.org/10.1182/blood-2012-06-435644
|
[44]
|
Banchereau, J., Thompson-Snipes, L., Zurawski, S., Blanck, J.P., Cao, Y., et al. (2012) The Differential Production of Cytokines by Human Langerhans Cells and Dermal CD14(+) DCs Controls CTL Priming. Blood, 119, 5742-5749. https://doi.org/10.1182/blood-2011-08-371245
|
[45]
|
Klechevsky, E., Morita, R., Liu, M., Cao, Y., Coquery, S., et al. (2008) Functional Specializations of Human Epidermal Langerhans Cells and CD14+ Dermal Dendritic Cells. Im-munity, 29, 497-510. https://doi.org/10.1016/j.immuni.2008.07.013
|
[46]
|
Leon, B., Lopez-Bravo, M. and Ardavin, C. (2007) Mono-cyte-Derived Dendritic Cells Formed at the Infection Site Control the Induction of Protective T Helper 1 Responses against Leishmania. Immunity, 26, 519-531. https://doi.org/10.1016/j.immuni.2007.01.017
|
[47]
|
Zou, W. and Restifo, N.P. (2010) T(H)17 Cells in Tumour Immunity and Immunotherapy. Nature Reviews Immunology, 10, 248-256. https://doi.org/10.1038/nri2742
|
[48]
|
Muranski, P. and Restifo, N.P. (2009) Does IL-17 Promote Tumor Growth? Blood, 114, 231-232. https://doi.org/10.1182/blood-2009-04-215541
|
[49]
|
Munn, D.H. (2009) Th17 Cells in Ovarian Cancer. Blood, 114, 1134-1135. https://doi.org/10.1182/blood-2009-06-224246
|
[50]
|
Bronte, V. (2008) Th17 and Cancer: Friends or Foes? Blood, 112, 214. https://doi.org/10.1182/blood-2008-04-149260
|